Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 3 Influence of clinical factors on D3R/βA, D5R/βA mRNA ratio in drug-med patients

From: Change of dopamine receptor mRNA expression in lymphocyte of schizophrenic patients

 

Sex

Age

Onset

duration

BPRS

dose

D3R/βA

NS*

NS*

NS*

NS*

NS*

NS*

D5R/βA

NS*

NS*

NS*

NS*

NS*

NS*

  1. *: NS; statistically non-significant